UP

US approves new drug to treat Alzheimer's disease

Home page Science
12 Punto 14 Punto 16 Punto 18 Punto
US approves new drug to treat Alzheimer's disease

The US Food and Drug Administration on Friday approved a highly anticipated new drug designed to slow cognitive decline in patients in mild and early stages of Alzheimer's disease.

Axar.az reports the FDA approval of the drug, Leqembi, also known as lecanemab, comes just days after the regulatory agency was harshly criticised in a congressional report for its green-lighting of another Alzheimer's drug, Aduhelm.

And it was granted despite trial results showing the monoclonal antibody treatment carries risks of brain swelling and bleeding.

Both drugs were approved through an accelerated process that allows the FDA to fast-track approval of drugs for serious conditions where there is an unmet medical need.

Date
2023.01.07 / 11:38
Author
Axar.az
See also

Hajiyev praises Vietnamese rendition of Azerbaijani song - Video

Trump vows to veto Democrats’ legislation

French parliament approves bill on police use of firearms

Magnitude 6.7 earthquake shakes Peru’s Andes

Paris braces for major demonstration on November 21

France and Sweden hold joint nuclear-deterrence exercise

Ilham Aliyev offers condolences to Georgian counterpart

Ilham Aliyev and To Lam adopted Joint Statement - Photo

Denmark plans to halt non-essential visas for Russian citizens

Aliyev held expanded meeting with President of Vietnam - Photo

Latest
Xocalı soyqırımı — 1992-ci il Bağla
Bize yazin Bağla
ArxivBağla